Related Experiment Video

Updated: Jul 9, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on

Elke Pogge von Strandmann1, Venkateswara Rao Simhadri, Bastian von Tresckow

  • 1Department of Internal Medicine I, University Hospital of Cologne, Kerpener Str. 62, D-50924 Cologne, Germany. elke.pogge@uk-koeln.de

Immunity
|December 7, 2007
PubMed

Insights

Natural killer (NK) cell activity relies on surface receptors. Researchers identified HLA-B-associated transcript 3 (BAT3) as a tumor cell-released ligand that binds NKp30, triggering NK cell cytotoxicity and tumor rejection.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Natural killer (NK) cell activity is regulated by surface receptors for target cell recognition.
  • NKp30 (Natural Cytotoxicity Receptor 3) is vital for NK cell-mediated lysis and dendritic cell interactions.
  • The specific cellular ligands for NKp30 have not yet been identified.

Purpose of the Study:

  • To identify the elusive cellular ligands for the NKp30 receptor.
  • To investigate the role of potential ligands in NK cell-mediated cytotoxicity and tumor rejection.

Main Methods:

  • Investigated the interaction between tumor cells and NK cells.
  • Utilized biochemical assays to detect binding of released factors to NKp30.
  • Assessed the functional impact of identified ligands on NK cell activity in vitro.
  • Evaluated the role of the ligand in a multiple myeloma tumor model.

Main Results:

  • The nuclear factor HLA-B-associated transcript 3 (BAT3) was found to be released from tumor cells.
  • BAT3 directly binds to the NKp30 receptor on NK cells.
  • BAT3 engagement triggers NKp30-mediated cytotoxicity.
  • BAT3 is essential for tumor rejection in a multiple myeloma model.

Conclusions:

  • HLA-B-associated transcript 3 (BAT3) is identified as a cellular ligand for NKp30.
  • This discovery proposes a novel mechanism for NK cell target recognition beyond existing paradigms.
  • Tumor cell-derived extracellular factors like BAT3 play a critical role in NK cell-mediated immunity.

More Related Videos

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells13:18

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

Related Concept Videos

Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.